The potential role of sodium glucose co‐transporter 2 inhibitors in the early treatment of type 2 diabetes mellitus

BACKGROUND: Sodium glucose co‐transporter 2 (SGLT2) inhibitors are a new class of pharmacologic agents developed for the treatment of type 2 diabetes mellitus (T2DM). Their unique mechanism of action is independent of pancreatic beta‐cell function or the degree of insulin resistance, giving these ag...

Descripción completa

Detalles Bibliográficos
Autor principal: Brunton, S. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Endocrinology & Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758393/
https://www.ncbi.nlm.nih.gov/pubmed/26147213
http://dx.doi.org/10.1111/ijcp.12675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758393/
https://www.ncbi.nlm.nih.gov/pubmed/26147213
http://dx.doi.org/10.1111/ijcp.12675

Ejemplares similares